PMDA adds patient adverse reaction reports (received Dec 1, 2025 – Mar 31, 2026)
患者副作用報告（2025年12月1日から2026年3月31日受付分）を追加しました
Published: 2026-07-13 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) posted a safety-update notice stating that patient adverse drug reaction reports received from December 1, 2025 to March 31, 2026 have been added to its patient reports page. This is a government announcement of added data; the metadata provided does not describe the contents of the reports.
Business Impact
Pharmaceutical companies and safety or pharmacovigilance teams may find the added reports relevant when monitoring patient-reported safety signals for their products. Any actual impact would depend on the specific reports, which are not described in the provided metadata.
Recommended Action
Review the official PMDA page in Japanese to confirm the content of the added reports and whether any of them relate to products of interest.